Literature DB >> 16182533

Verification of the turn at positions 22 and 23 of the beta-amyloid fibrils with Italian mutation using solid-state NMR.

Yuichi Masuda1, Kazuhiro Irie, Kazuma Murakami, Hajime Ohigashi, Ryutaro Ohashi, K Takegoshi, Takahiko Shimizu, Takuji Shirasawa.   

Abstract

The aggregation of 42-mer amyloid beta (Abeta42) plays a central role in the pathogenesis of Alzheimer's disease. Our recent research on proline mutagenesis of Abeta42 suggested that the formation of a turn structure at positions 22 and 23 could play a crucial role in its aggregative ability and neurotoxicity. Since E22K-Abeta42 (Italian mutation) aggregated more rapidly and with more potent neurotoxicity than wild-type Abeta42, the tertiary structure at positions 21-24 of E22K-Abeta42 fibrils was analyzed by solid-state NMR using dipolar-assisted rotational resonance (DARR) to identify the 'malignant' conformation of Abeta42. Two sets of chemical shifts for Asp-23 were observed in a ratio of about 2.6:1. The 2D DARR spectra at the mixing time of 500 ms suggested that the side chains of Asp-23 and Val-24 in the major conformer, and those of Lys-22 and Asp-23 in the minor conformer could be located on the same side, respectively. These data support the presence of a turn structure at positions 22 and 23 in E22K-Abeta42 fibrils. The formation of a salt bridge between Lys-22 and Asp-23 in the minor conformer might be a reason why E22K-Abeta42 is more pathogenic than wild-type Abeta42.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182533     DOI: 10.1016/j.bmc.2005.07.071

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Interprotofilament interactions between Alzheimer's Abeta1-42 peptides in amyloid fibrils revealed by cryoEM.

Authors:  Rui Zhang; Xiaoyan Hu; Htet Khant; Steven J Ludtke; Wah Chiu; Michael F Schmid; Carl Frieden; Jin-Moo Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-05       Impact factor: 11.205

2.  Zn(++) binding disrupts the Asp(23)-Lys(28) salt bridge without altering the hairpin-shaped cross-β Structure of Aβ(42) amyloid aggregates.

Authors:  Venus Singh Mithu; Bidyut Sarkar; Debanjan Bhowmik; Muralidharan Chandrakesan; Sudipta Maiti; Perunthiruthy K Madhu
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

3.  Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.

Authors:  Jitika Rajpoot; Elliot J Crooks; Brandon A Irizarry; Ashley Amundson; William E Van Nostrand; Steven O Smith
Journal:  Biochemistry       Date:  2022-06-06       Impact factor: 3.321

4.  A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.

Authors:  Lei Gu; Joyce Tran; Lin Jiang; Zhefeng Guo
Journal:  J Struct Biol       Date:  2016-01-28       Impact factor: 2.867

5.  Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes.

Authors:  Ellen Hubin; Stéphanie Deroo; Gabriele Kaminksi Schierle; Clemens Kaminski; Louise Serpell; Vinod Subramaniam; Nico van Nuland; Kerensa Broersen; Vincent Raussens; Rabia Sarroukh
Journal:  Cell Mol Life Sci       Date:  2015-07-21       Impact factor: 9.261

6.  Induced Dipole-Dipole Interactions Influence the Unfolding Pathways of Wild-Type and Mutant Amyloid β-Peptides.

Authors:  Justin A Lemkul; Jing Huang; Alexander D MacKerell
Journal:  J Phys Chem B       Date:  2015-12-15       Impact factor: 2.991

7.  Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.

Authors:  Ziao Fu; William E Van Nostrand; Steven O Smith
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

8.  An evaluation of the self-assembly enhancing properties of cell-derived hexameric amyloid-β.

Authors:  Devkee M Vadukul; Céline Vrancx; Pierre Burguet; Sabrina Contino; Nuria Suelves; Louise C Serpell; Loïc Quinton; Pascal Kienlen-Campard
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.